R. Mark Ghobrial

9.1k total citations · 1 hit paper
135 papers, 5.1k citations indexed

About

R. Mark Ghobrial is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, R. Mark Ghobrial has authored 135 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Surgery, 75 papers in Hepatology and 41 papers in Epidemiology. Recurrent topics in R. Mark Ghobrial's work include Organ Transplantation Techniques and Outcomes (62 papers), Liver Disease and Transplantation (54 papers) and Liver Disease Diagnosis and Treatment (29 papers). R. Mark Ghobrial is often cited by papers focused on Organ Transplantation Techniques and Outcomes (62 papers), Liver Disease and Transplantation (54 papers) and Liver Disease Diagnosis and Treatment (29 papers). R. Mark Ghobrial collaborates with scholars based in United States, China and Japan. R. Mark Ghobrial's co-authors include Ronald W. Busuttil, Ashish Saharia, David W. Victor, Howard Monsour, Emad H. Asham, Sherilyn Gordon Burroughs, Maha Boktour, Julius Balogh, Sammy Saab and Xian Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

R. Mark Ghobrial

131 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocellular carcinoma: a review

2016 840 citations David W. Victor, Ashish Saharia et al. SHILAP Revista de lepidopterología profile →

Peers

R. Mark Ghobrial

HEPAT

SURGE

EPIDE

ONCOL

PHEOH

Massimo Rossi Italy

Franco Filipponi Italy

Ryutaro Hirose United States

Kwang‐Woong Lee South Korea

Maarten J. H. Slooff Netherlands

Lünan Yan China

Eberhard L. Renner Canada

Jeffrey S. Crippin United States

James D. Perkins United States

Elizabeth C. Verna United States

Massimo Rossi Italy

R. Mark Ghobrial

2.6k ×0.8

HEPAT

2.1k ×0.8

SURGE

1.6k ×0.9

EPIDE

544 ×1.0

ONCOL

359 ×0.7

PHEOH

Citations per year, relative to R. Mark Ghobrial R. Mark Ghobrial (= 1×) peers Massimo Rossi

Countries citing papers authored by R. Mark Ghobrial

Since Specialization

Citations

This map shows the geographic impact of R. Mark Ghobrial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Mark Ghobrial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Mark Ghobrial more than expected).

Fields of papers citing papers by R. Mark Ghobrial

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Mark Ghobrial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Mark Ghobrial. The network helps show where R. Mark Ghobrial may publish in the future.

Co-authorship network of co-authors of R. Mark Ghobrial

This figure shows the co-authorship network connecting the top 25 collaborators of R. Mark Ghobrial. A scholar is included among the top collaborators of R. Mark Ghobrial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Mark Ghobrial. R. Mark Ghobrial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nigo, Masayuki, Stefano Casarin, Max W. Adelman, et al.. (2025). Bloodstream infection subtypes and characteristics comparing solid organ transplant and nontransplant populations. American Journal of Transplantation. 26(2). 404–417.

Kodali, Sudha, Constance M. Mobley, Ashish Saharia, et al.. (2024). Effect of a Hispanic outreach program on referral and liver transplantation volume at a single center. Transplant Immunology. 84. 102034–102034. 3 indexed citations

Abdelrahim, Maen, Abdullah Esmail, Aiwu Ruth He, et al.. (2024). Circulating tumor DNA monitoring for recurrence detection and treatment response assessment in HCC. HPB. 26. S605–S605. 1 indexed citations

Adelman, Max W., Ashton A. Connor, Ashish Saharia, et al.. (2023). Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21). JAC-Antimicrobial Resistance. 6(1). dlad158–dlad158. 14 indexed citations

Kodali, Sudha, et al.. (2023). Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: Past, present, and future directions. Hepatobiliary & pancreatic diseases international. 23(2). 129–138. 6 indexed citations

Abdelrahim, Maen, Abdullah Esmail, Aiwu Ruth He, et al.. (2023). 960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC). Annals of Oncology. 34. S600–S600. 2 indexed citations

Swan, Joshua T., Stephen L. Jones, Juan Nicolás, et al.. (2022). Hospitalization and survival of solid organ transplant recipients with coronavirus disease 2019: A propensity matched cohort study. PLoS ONE. 17(12). e0278781–e0278781. 4 indexed citations

Huang, Howard J., Stephanie G. Yi, Constance M. Mobley, et al.. (2022). Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients. Clinical Transplantation. 36(5). e14600–e14600. 9 indexed citations

Bae, Sunjae, Jennifer L. Alejo, Teresa Po‐Yu Chiang, et al.. (2022). mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients. American Journal of Transplantation. 22(12). 3137–3142. 12 indexed citations

10.

Eubank, Taryn A, Constance M. Mobley, Mark J. Hobeika, et al.. (2021). Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population. SHILAP Revista de lepidopterología. 2021. 1–7. 6 indexed citations

11.

Hibi, Taizo, Mohamed Rela, James D. Eason, et al.. (2020). Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference. Transplantation. 104(6). 1131–1135. 29 indexed citations

12.

Sapisochín, Gonzalo, Taizo Hibi, R. Mark Ghobrial, & Kwan Man. (2020). The ILTS Consensus Conference on Transplant Oncology: Setting the Stage. Transplantation. 104(6). 1119–1120. 10 indexed citations

13.

Mehta, Neil, Prashant Bhangui, Francis Y. Yao, et al.. (2020). Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation. 104(6). 1136–1142. 134 indexed citations

14.

Tsochatzis, Emmanuel, Audrey Coilly, Silvio Nadalin, et al.. (2018). International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. Transplantation. 103(1). 45–56. 61 indexed citations

15.

Kayler, Liise K., et al.. (2015). American Society of Transplant Surgeons: 16th. American Journal of Transplantation. 16. 9–90. 1 indexed citations

16.

Fischer, Craig P., et al.. (2009). Timing of referral impacts surgical outcomes in patients undergoing repair of bile duct injuries. HPB. 11(1). 32–37. 38 indexed citations

17.

Baibakov, Boris, et al.. (2005). Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection. Transplantation Proceedings. 37(1). 35–36. 1 indexed citations

18.

Saab, Sammy, Ayman Ibrahim, Zobair M. Younossi, et al.. (2005). MELD fails to measure quality of life in liver transplant candidates. Liver Transplantation. 11(2). 218–223. 94 indexed citations

19.

Ghobrial, R. Mark. (2003). Retransplantation for recurrent hepatitis C in the model for end-stage liver disease era: How should we or shouldn’t we?. Liver Transplantation. 9(10). 1025–1027. 8 indexed citations

20.

Testa, Giuseppe, Sukru Emre, L Grande, et al.. (2002). Safety and efficacy of single bolus dose of recombinant factor VIIA in patients undergoing orthotopic liver transplantation: A randomized mulit-center study.. Data Archiving and Networked Services (DANS). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact